| Name | Title | Contact Details |
|---|
Mayer LLP is a law firm formed by a group of experienced attorneys dedicated to providing comprehensive legal services across various sectors. The firm focuses on delivering high-quality legal solutions by leveraging the collective expertise of its attorneys. The firm offers a wide range of legal services, including appellate representation, corporate governance, healthcare compliance, immigration guidance, labor and employment advice, complex litigation management, real estate transactions, and trial consulting. Mayer LLP serves diverse industries, particularly healthcare and manufacturing, addressing specific legal issues and fostering long-term client relationships.
United Semiconductor is a Clifton Park, NY-based company in the Business Services sector.
Oculis (Nasdaq: OCS) is a global biopharmaceutical company purposefully driven to save sight and improve eye care. Oculis highly differentiated clinical-stage pipeline comprises multiple innovative product candidates in development for eye diseases of high unmet need. It includes OCS-01 eye drops, a topical candidate in Phase 3 development for diabetic macular edema (DME) and inflammation and pain following ocular surgery; OCS-02 eye drops, a topical biologic candidate in Phase 2 development for dry eye disease (DED) and uveitis; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophthalmic disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The first in-patient, proof-of-concept trial with OCS-05 is currently ongoing in France. Headquartered in Switzerland and with operations in the US, Europe, and China, Oculis goal is to deliver life-changing eye treatments to patients worldwide. The company is led by an experienced management team with a successful track record in the pharmaceutical industry, supported by leading international healthcare investors.
River Bend Ctr-Mental Health is a Florence, AL-based company in the Business Services sector.
Hydrogen-XT, Inc. is a privately held company founded in 2010. We believe that hydrogen has the potential to become the primary transportation fuel in the United States if it can overcome the cost-prohibitive nature of building the required fueling infrastructure enabling consumers to purchase and drive hydrogen-powered fuel cell vehicles (FCVs). The company has developed a small-footprint, scalable and standardized hydrogen fueling station that processes natural gas or biogas, small amounts of water and electricity to produce dispensable, cost-competitive hydrogen fuel on-site using a steam methane reformer (SMR). All Hydrogen-XT stations will use a proprietary reservation system and a mobile interface that will provide the consumer with real-time location, reservation and secure transaction processing while constantly monitoring the equipment for the operator. A technology patent for this design was granted in February 2014. Hydrogen-XT, Inc. is currently in the process of building a pilot station in California. After completion of this pilot, the company will use privately raised investment capital in conjunction with federal and state funds to deploy a network of stations throughout California and other states with Zero Emission Vehicle (ZEV) standards. At Hydrogen-XT, Inc. we work hard to support the roll-out of the next-generation zero-emissions fuel cell vehicles across the United States. Our technology can help surpass the carbon emission reductions prescribed by federal and state ZEV mandates ahead of the demanded time frames. Since our SMRs operate on biogas, we not only enable consumers fueling their FCVs to reduce emissions, but also offer an alternative use for methane, a greenhouse gas that in the past has often been flared or simply released into the atmosphere, significantly contributing to climate change. Converting methane into hydrogen reduces its carbon content by over 36%. Hydrogen. A simple element that solves a complicated problem.